Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
2.410
+0.470 (24.23%)
At close: Nov 4, 2024, 4:00 PM
2.430
+0.020 (0.83%)
After-hours: Nov 4, 2024, 7:59 PM EST

Tenaya Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Selling, General & Admin
33.2933.1631.0818.417.814.56
Research & Development
93.6698.0494.5454.3931.123.15
Operating Expenses
126.95131.19125.6272.8138.9127.71
Operating Income
-126.95-131.19-125.62-72.81-38.91-27.71
Interest & Investment Income
6.097.061.950.110.090.45
Other Non Operating Income (Expenses)
0.120.050-0.020.391.03
EBT Excluding Unusual Items
-120.74-124.08-123.67-72.72-38.44-26.23
Gain (Loss) on Sale of Assets
-----0.03-0.01
Other Unusual Items
----0.080.01
Pretax Income
-120.74-124.08-123.67-72.72-38.4-26.23
Net Income
-120.74-124.08-123.67-72.72-38.4-26.23
Net Income to Common
-120.74-124.08-123.67-72.72-38.4-26.23
Shares Outstanding (Basic)
7974451811
Shares Outstanding (Diluted)
7974451811
Shares Change (YoY)
29.65%64.61%152.75%1724.33%28.62%-
EPS (Basic)
-1.53-1.68-2.76-4.10-39.50-34.71
EPS (Diluted)
-1.53-1.68-2.76-4.10-39.50-34.71
Free Cash Flow
-98.88-103.31-125.05-85.93-45.21-27.02
Free Cash Flow Per Share
-1.25-1.40-2.79-4.85-46.51-35.75
EBITDA
-118.31-122.51-119.15-69.85-36.43-25.72
D&A For EBITDA
8.648.696.472.962.481.99
EBIT
-126.95-131.19-125.62-72.81-38.91-27.71
Source: S&P Capital IQ. Standard template. Financial Sources.